Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Neurochem. 2013 Jul 19;127(4):10.1111/jnc.12360. doi: 10.1111/jnc.12360

Figure 5.

Figure 5

Effects of exogenous administration J1-34 and MIA-602 on EPO (A) and IGF-1 (B) mRNA expression. EPO and IGF-1 mRNA expression was assessed by quantitative real-time RT-PCR. J1-34 administration induced significant increases in IGF-1 mRNA and EPO expression during exposures to IH. Data are mean ± SEM. (*IH-VEH and IH-JI34 vs. RA-VEH, p <0.01; One-way ANOVA).